Pelvital USA Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$3M
- Investors
-
7
Pelvital USA General Information
Description
Developer of a medical device designed to treat mild, moderate, and severe female stress urinary incontinence. The company's device uses technology capable of delivering mechanotherapy, which is a proven method for healing and strengthening muscle systems, enabling patients who suffer from pelvic floor disorders to significantly improve their lives.
Contact Information
Website
flytetherapy.comCorporate Office
- 860 Blue Gentian Road
- Suite 200
- Eagan, MN 55121
- United States
Corporate Office
- 860 Blue Gentian Road
- Suite 200
- Eagan, MN 55121
- United States
Pelvital USA Timeline
Pelvital USA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 21-Oct-2026 | $3M | In Progress | Generating Revenue | ||
| 5. Later Stage VC | 27-Apr-2026 | Completed | Generating Revenue | |||
| 4. Seed Round | 13-Sep-2024 | Completed | Generating Revenue | |||
| 3. Seed Round | 26-Apr-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | $6.58M | Completed | Generating Revenue | |||
| 1. Seed Round | 14-Dec-2021 | $6.58M | $6.58M | Completed | Generating Revenue |
Pelvital USA Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pelvital USA Patents
Pelvital USA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3917483-B1 | Adjustable apparatus for cellular restructuring | Active | 01-Feb-2019 | ||
| EP-3917483-C0 | Adjustable apparatus for cellular restructuring | Active | 01-Feb-2019 | ||
| EP-3917483-A1 | Adjustable apparatus, system, and method for cellular restructuring | Active | 01-Feb-2019 | ||
| EP-3917483-A4 | Adjustable apparatus, system, and method for cellular restructuring | Active | 01-Feb-2019 | ||
| EP-3723875-B1 | Apparatus for tissue regeneration | Active | 13-Dec-2017 | A61H21/00 |
Pelvital USA Signals
Pelvital USA Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boomerang Ventures | Venture Capital | Minority | ||
| Life Science Angels | Angel Group | Minority | ||
| Pier 70 Ventures | Venture Capital | Minority | ||
| TCA Venture Group | Angel Group | Minority | ||
| VisionTech Partners | Angel Group | Minority |
Pelvital USA FAQs
-
When was Pelvital USA founded?
Pelvital USA was founded in 2016.
-
Where is Pelvital USA headquartered?
Pelvital USA is headquartered in Eagan, MN.
-
What is the size of Pelvital USA?
Pelvital USA has 10 total employees.
-
What industry is Pelvital USA in?
Pelvital USA’s primary industry is Therapeutic Devices.
-
Is Pelvital USA a private or public company?
Pelvital USA is a Private company.
-
What is Pelvital USA’s current revenue?
The current revenue for Pelvital USA is .
-
How much funding has Pelvital USA raised over time?
Pelvital USA has raised $16.1M.
-
Who are Pelvital USA’s investors?
Boomerang Ventures, Life Science Angels, Pier 70 Ventures, TCA Venture Group, and VisionTech Partners are 5 of 7 investors who have invested in Pelvital USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process